American Pharmacy News
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • Home
  • »
  • Stories
  • »
  • Featured

Waismann group warns of new fentanyl analogue that is naloxone-resistant

Ruth de Jauregui | May 13, 2017
An illegal drug like heroin may be laced with other drugs, such as fentanyl or acryfentanyl, in an effort to increase its effects.

Waismann Method Medical Group directors have warned of a new naloxone-resistant drug hitting the streets, calling for an awareness program for acrylfentanyl and warning of a serious public health emergency. Read More »

Imprimis introduces new treatment for glaucoma

Carrie Bradon | May 11, 2017
Glaucoma makes up a huge portion of the opthalmic market in the U.S.

Imprimis Pharmaceutical Inc. launch its new Simple drops glaucoma drops at the American Society of Cataract and Refractive Surgery 2017 meeting at the Los Angeles Convention Center this month. Read More »

Express Scripts announces plan to provide discounted medications to uninsured

John Breslin | May 11, 2017
InsideRx, a program by Express Scripts designed to provide drug discounts to the uninsured, already has partners in Walgreens and CVS, a spokeswoman said.

A major pharmacy benefit manager has announced a program to provide discounted drugs to uninsured Americans. Read More »

Analyst argues PBMs help keep drug prices down

John Breslin | May 9, 2017
Two bills, one in the House and one in the Senate, centering on the transparency of PBMs have been filed ths year.

Pharmacy benefit managers should be praised for helping to keep down the cost of prescription drugs, rather than attacked by Congress and others, according to one health policy adviser. Read More »

Singer Lovato helps release mental health documentary

Mark Iandolo | May 8, 2017
Demi Lovato served as executive producer of the documentary

Sunovion Pharmaceuticals Inc., five leading mental health advocacy organizations and singer, songwriter and mental health advocate Demi Lovato recently released "Beyond Silence," a documentary about their experience with speaking out for mental health. Read More »

PharmaCyte Biotech to receive 2017 Buzz of BIO award

Carrie Bradon | May 3, 2017
Among topics to be discussed will be drug discovery, biomanufacturing, biofuels and cell therapy.

PharmaCyte Biotech, Inc., announced that they would be winning the 2017 Buzz of BIO "Pipelines of Promise" award prior to the 2017 BIO International Convention. Read More »

Martin to join Purdue Pharma as VP of corporate affairs

Carrie Bradon | May 2, 2017
Josie Martin has held positions at Ketchum, the Federation of American Hospitals and the American Red Cross.

Josie Martin has been named vice president of corporate affairs and communications for Purdue Pharma LP. Read More »

Biologics chosen as specialty pharmacy provider for ZEJULA

Carrie Bradon | May 1, 2017
The American Cancer Society states that there are more than 22,000 women who will be diagnosed with ovarian cancer this year.

Biologics Inc., a McKesson Specialty Health oncology pharmacy services company, has been chosen by Tesaro Inc. to provide its new drug. Read More »

European authorities grant Shire's Natpar approval for human use

Mark Iandolo | Apr 28, 2017
Hypoparathyroidism is the last endocrine disorder for which there is no hormone treatment.

Shire PLC's Natpar, an adjunctive treatment for adult patients with chronic hypoparathyroidism, was reviewed positively by the Committee for Medicinal Products for Human Use of the European Medicines Agency. Read More »

Video trains health care professionals to treat opioid overdoses

Mark Iandolo | Apr 24, 2017
The project involves a 19-minute video titled “Opioid Overdose and Naloxone Reversal.”

The American Society of Health-System Professionals recently launched a pharmacy project aimed at training emergency medical services and law enforcement personnel on how to deliver naloxone to opioid-overdosed individuals. Read More »

'Meds to beds': personal delivery helps patients following hospital discharge

Carrie Bradon | Apr 21, 2017

Bedside delivery of medications is a practice that is helping patients live more healthily following discharge from hospitals. Read More »

Allergan, Ironwood Pharmaceuticals raise awareness of IBS

Carrie Bradon | Apr 20, 2017
The Vital Signs of Bowel Health Summit was held in New York City.

Allergan PLC and Ironwood Pharmaceuticals Inc. merged forces with the American Gastroenterological Association to raise awareness about bowel health during Irritable Bowel Syndrome Awareness Month. Read More »

Many large patient advocacy groups receive funding from drug industry, study says

John Breslin | Apr 18, 2017

A majority of the biggest patient advocacy groups in the country received drug industry funding last year, with many receiving as much as $1 million or more, a study has found. Read More »

CVS Health's Advanced Care Scripts attains URAC accreditation

Carrie Bradon | Apr 18, 2017
CVS Health's Advanced Care Scripts distributes specialty medications to customers who suffer from more complicated health issues.

CVS Health's Advanced Care Scripts has earned accreditation in Specialty Pharmacy from URAC, the leader in health care accreditation, certification and overall measurement. Read More »

Alcon receives FDA approval for AcrySof intraocular lenses

Mark Iandolo | Apr 13, 2017
AcrySof is the market leader for surgeons specializing in cataracts surgeries.

Alcon, a division of Novartis, has received approval from the U.S. Food and Drug Administration for its AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens with ActiveFocus optical design. The product was made for patients with an astigmatism and presbyopia who want to treat them both at the same time with cataract surgery. Read More »

Experts argue pharmacists are first line of defense in opioid epidemic

Tabitha Fleming | Apr 12, 2017
The prevalence of opioid abuse was the topic of a recent special issue of the Journal of the American Pharmacists Association.

Pharmacists and the difficult balance they must keep between patients suffering from chronic pain and the prevalence opioid abuse was the topic of a recent special issue of the Journal of the American Pharmacists Association Read More »

Daiichi Sankyo enrolls first patient in Eliminate-AF study

Mark Iandolo | Apr 10, 2017
Lixiana is designed to fight Vitamin K antagonists in patients with atrial fibrillation undergoing catheter ablation.

Daiichi Sankyo Inc. recently announced the enrollment of the first person for its Eliminate-AF study. Read More »

Panacea successfully targets, kills leukemia cells

Ruth de Jauregui | Apr 8, 2017
A Phase I trial for prostate cancer patients using the PAN-301-1 therapeutic cancer vaccine was recently completed.

The paper "Radioimmunotherapy for Acute Myeloid Leukemia Targeting Human Aspartyl (Asparaginyl) β-Hydroxylase” was presented at the American Association for Cancer Research (AACR) meeting by Panacea Pharmaceuticals on April 3. Read More »

Bristol-Myers and Incyte to launch Phase 3 studies of drug combination

Mark Iandolo | Apr 6, 2017

Bristol-Myers Squibb Co. and Incyte Corp. have agreed to advance their clinical development program. Read More »

Senators warned to avoid tampering with Medicare drug pricing

John Breslin | Apr 3, 2017
Sen. Ron Wyden's proposal would require a minimum percentage of rebates and discount to be passed from a PBM to a health plan.

Senators pushing for changes to Medicare Part D drug pricing reporting requirements should be wary of messing with the program, according to a former administrator of the Centers for Medicare and Medicaid Services. Read More »

  • «
  • 1
  • 2
  • ...
  • 12
  • 13
  • 14 (current)
  • 15
  • 16
  • 17
  • 18
  • 19
  • »
Trending

Jennifer Riley, Executive Director, Patients Come First

Patients Come First executive director: Misleading lawsuit ads leave 'patients confused and unprotected’

Sarah Emond, President and Chief Executive Officer for ICER

ICER report highlights patent review as key to lowering GLP-1 drug costs

 B. Douglas Hoey CEO

NCPA and APA defend Arkansas law separating PBM operations from pharmacy ownership

Sally Pipes, President & CEO of Pacific Research Institute

Pacific Research Institute CEO on 340B program: 'Even the most well-intentioned government initiatives can easily fall victim to corruption'

 B. Douglas Hoey CEO

NCPA releases national map highlighting U.S. pharmacy shortage areas

Copyright © 2025 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up